VYNE Therapeutics, Inc. (VYNE)
0.5668
0.00 (0.00%)
USD |
NASDAQ |
Jan 16, 16:00
0.5677
0.00 (0.00%)
After-Hours: 20:00
VYNE Therapeutics Market Cap: 18.87M for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.421B |
| Theravance Biopharma, Inc. | 1.014B |
| Recursion Pharmaceuticals, Inc. | 2.431B |
| NovaBay Pharmaceuticals, Inc. | 1.861B |
| Palatin Technologies, Inc. | 16.31M |
Market Cap Related Metrics
| PS Ratio | 46.20 |
| Price to Book Value | 0.588 |
| Price | 0.5668 |
| Earnings Yield | -139.1% |